Average Co-Inventor Count = 8.53
ph-index = 31
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Rigel Pharmaceuticals, Incorporated (85 from 488 patents)
2. Rogel Pharmaceuticals, Inc. (1 from 1 patent)
86 patents:
1. 11827628 - Compositions and methods for inhibition of the JAK pathway
2. 11667611 - Compositions and methods for inhibition of the JAK pathway
3. 11230554 - Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
4. 11198689 - Compositions and methods for inhibition of the JAK pathway
5. 11021468 - TGF-ß inhibitors
6. 11007193 - 2,4-pyrimidinediamine compounds and their uses
7. 10828301 - 2,4-pyrimidinediamine compounds and their uses
8. 10709703 - 2,4-pyrimidinediamine compounds and their uses
9. 10682350 - 2,4-pyrimidinediamine compounds and their uses
10. 10421752 - Compositions and methods for inhibition of the JAK pathway
11. 10369148 - 2,4-pyrimidinediamine compounds and their uses
12. 10314840 - 2,4-pyrimidinediamine compounds and their uses
13. 10259826 - Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
14. 9913842 - 2,4-pyrimidinediamine compounds and their uses
15. 9878992 - GDF-8 inhibitors